Pharma Market Intelligence
Transform the way you do business with intelligence that empowers you to make smarter commercial decisions in less time, helping you achieve accelerated growth in the pharmaceutical market.
Transform the way you do business with intelligence that empowers you to make smarter commercial decisions in less time, helping you achieve accelerated growth in the pharmaceutical market.
The full Scrip Asia 100 report includes:
• Common themes throughout the region
• Top 100 Pharma Companies including sales figures
• Top 20 companies by region
• Fastest growing and shrinking companies
• Innovation models and strategies being used
The Market Analysis tool helps you to pull together competitive analysis by locating and exporting the vital data you need, with minimal time and effort. Covering hundreds of device and diagnostic product types, the Market Analysis tool empowers you to quickly find and export the critical information you need, like:
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
After a week of monoclonal antibody therapies hitting the headlines - including a personal endorsement from President Trump - the US government bulks up its potential supplies. AZ's long-acting monoclonal antibody product enters large-scale trials for both a treatment and prophylaxis of COVID-19.
Topic Coronavirus
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
It will be several days at least before more information is available about the unexpected illness in J&J's Phase III COVID-19 vaccine trial, the firm said during its third quarter financial call.
Topic Coronavirus clinical-trials
HBW Insight : コンシューマーヘルスケア産業のニュース, Generics Bulletin: ジェネリック...
Keep up with topics you care about in Pharma and Medtech with the new Alexa Skill from Informa Pharma Intelligence. Access daily news briefings to stay up to date with the latest news, right from your Alexa smartphone app!
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース, Datamonitor Healthcare: 医療用医薬...
In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.
Topic drug-review diseases
Join our panel of experts as they discuss the impact of COVID-19 on clinical trials, the new normal and future pathways to get ahead. Get the latest insights and status on recent clinical trials, the emergence of virtual trials, and what you need to know for success.
Gain Clarity of Sight into What Comes Next with Citeline According to Informa’s Pharmaprojects, less than 3% of all rare congenital and genetic diseases have an approved therapy. Opportunities abound if you know the risks. Make better strategic and planning decisions with Intelligence services that give you a clear line of sight, helping you maximize clinical and commercial opportunities, navigate uncertainties, and ensure more successful outcomes.
Medtech Insight: 世界の医療機器・医療技術の最新情報
Coronavirus has diverted the focus of health systems away from early cancer detection, says a new report by Cancer Research UK, urging a rebalancing of priorities.
Topic cancer policy-and-regulation
Medtech Insight: 世界の医療機器・医療技術の最新情報
The American Medical Association has added two new Current Procedural Terminology (CPT) codes for reporting antigen tests that detect COVID-19 and influenza. And a third new code, 87811, should be used to report “infectious agent antigen detection by immunoassay with direct visual observation.”
Topic Coronavirus
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Join us for an audio roundup of major events in the international biopharma industry over the past week, as reported by Scrip's global team
Topic Coronavirus clinical-trials
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Results from a Phase II/III study for VIR-7831 in the prevention of hospitalization due to COVID-19 are expected in late 2020 and early 2021.
Topic Coronavirus research
Pink Sheet: 世界の薬事規制と承認審査に関するニュース, Scrip: 世界の医療用医薬品＆製薬産業に関するニ...
Trump receives Regeneron’s experimental antibody under FDA’s expanded access program, Gilead’s remdesivir and dexamethasone. The president’s treatment choices could influence clinical trials of all COVID-19 medicines and even trial recruitment for other diseases, experts said.
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
Textualist judges appointed by President Trump during his term may block a potential President Biden’s attempts to shift the government’s legal policies.
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
‘Senator, please stop undermining confidence in a vaccine,’ Pence says when confronted with the accusation that the administration is politicizing the COVID vaccine development effort.
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
Delegates at this week’s TOPRA conference heard the European Commission’s “holistic” vision of what it would like to achieve through its pharmaceutical strategy, including incentives for innovation, security of the supply chain, product shortages, real world evidence and big data, and the availability and affordability of medicines.
製品説明＆デモお申込
専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。
＊一部のサービスでは無料トライアルをご利用になれません。
お問い合わせ先
ご質問等ございましたらお気軽にご連絡下さい。
日本（平日：9時～18時）
電話：+81 (0)3 6273 4260
Email：inquiry.jp@informa.com
レポートストア
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。
